Prediction of pathological complete response after neoadjuvant treatment in triple negative breast cancer: a single center experience
Pamukkale Medical Journal · 13.04.2026 · 19 (2) · 237-242
DOI: 10.31362/patd.1707522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pamukkale Medical Journal, online erschienen am 13.04.2026. Verfasst von Ece Ulukal Karancı und 2 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Purpose
To identify clinicopathological factors associated with pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in patients with triple-negative breast cancer (TNBC).Matherials and methods: A retrospective study of 51 women with stage I–III TNBC who received NAC between January 2019 and December 2024 at Antalya Training and Research Hospital. Binary logistic regression was used to determine independent predictors of pCR.
Results
The median age was 49 years (range: 28-79), and 28 patients (54.9%) achieved pCR. Patients aged ≥60 were significantly less likely to achieve pCR (OR: 0.22; 95% CI: 0.05-0.98; p=0.048*). No significant associations were found for carboplatin or pembrolizumab use.
Conclusion
This real-world cohort confirms that pCR rates are consistent with literature. Advanced age was a significant negative predictor, emphasizing the importance of personalized approaches in elderly patients.
Zitieren
APA
Karancı, E. U., Güzel, H. G., & Öztürk, B. (2026). Prediction of pathological complete response after neoadjuvant treatment in triple negative breast cancer: a single center experience. Pamukkale Medical Journal, 19(2), 237-242. https://doi.org/10.31362/patd.1707522
Vancouver
Karancı EU, Güzel HG, Öztürk B. Prediction of pathological complete response after neoadjuvant treatment in triple negative breast cancer: a single center experience. Pamukkale Medical Journal. 2026;19(2):237-242. doi:10.31362/patd.1707522
BibTeX
@article{Karanc2026,
author = {Karancı, Ece Ulukal and Güzel, Halil Göksel and Öztürk, Banu},
title = {Prediction of pathological complete response after neoadjuvant treatment in triple negative breast cancer: a single center experience},
journal = {Pamukkale Medical Journal},
year = {2026},
volume = {19},
number = {2},
pages = {237--242},
doi = {10.31362/patd.1707522}
}
EUVIMED